Porcine adenovirus type 5 vector and vaccine
CA 2413265 A1 · Owner: Tuboly, Tamas · Inventors: Nagy, Eva; Nagy, Miklos; Tuboly, Tamas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The entire nucleotide sequence of porcine adenovirus serotype 5 (PAdV-5) is described as are methods of inserting heterologous nucleotide sequences such , as the TGEV S gene, into the E3 region of the virus. Vaccines and methods of preparing vaccines with the recombinant adenovirus are described as well as applications of the recombinant virus and vaccines.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 3, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 3, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 3, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.